|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:available_in
|
gptkb:various_countries
|
|
gptkbp:brand
|
gptkb:Bisolvon
|
|
gptkbp:clinical_trial
|
Bromhexine efficacy study
Bromhexine safety study
|
|
gptkbp:clinical_use
|
respiratory conditions
|
|
gptkbp:contraindication
|
hypersensitivity
peptic ulcer
|
|
gptkbp:dosage_form
|
gptkb:tablet
gptkb:liquid
varies by age
8 mg
16 mg
30 mg/5 ml
|
|
gptkbp:effect_on_cough
|
reduces cough frequency
|
|
gptkbp:effect_on_mucus
|
thins mucus
|
|
gptkbp:effect_on_respiratory_system
|
improves airway clearance
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:financial_support
|
consult doctor if symptoms persist
drink plenty of fluids
|
|
gptkbp:formulation
|
gptkb:Software_Solutions
gptkb:Sugar
tablets
|
|
gptkbp:history
|
introduced in the 1960s
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bisolvon
|
|
gptkbp:indication
|
chronic bronchitis
acute bronchitis
mucus clearance
|
|
gptkbp:ingredients
|
bromhexine
|
|
gptkbp:interacts_with
|
antibiotics
other cough medications
|
|
gptkbp:is_involved_in
|
gptkb:children
adults
|
|
gptkbp:manufacturer
|
gptkb:Boehringer_Ingelheim
|
|
gptkbp:mechanism_of_action
|
mucolytic agent
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:packaging
|
gptkb:bottle
blister pack
|
|
gptkbp:pharmacokinetics
|
absorbed in gastrointestinal tract
|
|
gptkbp:related_to
|
expectorants
mucolytics
|
|
gptkbp:requires
|
over-the-counter
|
|
gptkbp:route_of_administration
|
oral
|
|
gptkbp:sales
|
widely used
|
|
gptkbp:shelf_life
|
3 years
|
|
gptkbp:side_effect
|
nausea
diarrhea
stomach pain
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:used_for
|
cough relief
|
|
gptkbp:bfsParent
|
gptkb:bisoprolol
|
|
gptkbp:bfsLayer
|
8
|